Molecular predictor and promising target: will EGFR now become a star in radiotherapy?
Radiother Oncol
.
2005 Feb;74(2):89-91.
doi: 10.1016/j.radonc.2005.01.004.
Author
Guido Lammering
PMID:
15734197
DOI:
10.1016/j.radonc.2005.01.004
No abstract available
Publication types
Editorial
MeSH terms
Biomarkers, Tumor / analysis*
ErbB Receptors / physiology*
Humans
Neoplasms / physiopathology*
Neoplasms / radiotherapy*
Phenotype
Prognosis
Radiation Tolerance*
Substances
Biomarkers, Tumor
ErbB Receptors